Reaction Details Report a problem with these data
Target
C-C chemokine receptor type 5
Ligand
BDBM50124952
Substrate
n/a
Meas. Tech.
ChEMBL_39639 (CHEMBL649945)
Ki
14±n/a nM
Citation
 Debnath, AK Generation of predictive pharmacophore models for CCR5 antagonists: study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors. J Med Chem 46:4501-15 (2003) [PubMed]  Article 
Target
Name:
C-C chemokine receptor type 5
Synonyms:
C-C CKR-5 | C-C chemokine receptor type 5 | CC-CKR-5 | CCR-5 | CCR5 | CCR5/mu opioid receptor complex | CCR5_HUMAN | CD_antigen=CD195 | CHEMR13 | CMKBR5 | HIV-1 fusion coreceptor
Type:
Enzyme
Mol. Mass.:
40540.21
Organism:
Homo sapiens (Human)
Description:
P51681
Residue:
352
Sequence:
MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKRLKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFIILLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSSHFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTIMIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFVGEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL
  
Inhibitor
Name:
BDBM50124952
Synonyms:
(4-{(4-Bromo-phenyl)-[(E)-2,2,2-trifluoro-ethoxyimino]-methyl}-4'-methyl-[1,4']bipiperidinyl-1'-yl)-(4,6-dimethyl-pyrimidin-5-yl)-methanone | CHEMBL141201
Type:
Small organic molecule
Emp. Form.:
C27H33BrF3N5O2
Mol. Mass.:
596.482
SMILES:
Cc1ncnc(C)c1C(=O)N1CCC(C)(CC1)N1CCC(CC1)C(=N/OCC(F)(F)F)\c1ccc(Br)cc1
Structure:
Search PDB for entries with ligand similarity: